ANAVEX 2-73 (blarcamesine) — IND submission
Sep 2026
We plan to submit an IND for ANAVEX 2-73 for the treatment of Fragile X syndrome in September 2026.Source filing
AVXL biotech catalysts & pipeline
ANAVEX LIFE SCIENCES CORP · Data as of 2026-09-08
ANAVEX LIFE SCIENCES CORP · Data as of 2026-09-08
Sep 2026
We plan to submit an IND for ANAVEX 2-73 for the treatment of Fragile X syndrome in September 2026.Source filing